Midatech taps Stephen Parker as its new chairman
10th Jun 2022 12:25
(Sharecast News) - Biotechnology company Midatech Pharma announced on Friday that its chairman and non-executive director Rolf Stahel intends to retire after its annual general meeting on 20 June.
Read moreMidatech extends work with Janssen to another experimental molecule
9th Mar 2022 14:26
(Sharecast News) - Drug delivery technology company Midatech Pharma announced an extension of its existing research and development collaboration with Johnson & Johnson subsidiary Janssen Pharmaceuticals, agreed in July 2020.
Read moreMidatech Pharma interim losses narrow
17th Sep 2021 12:28
(Sharecast News) - Drug delivery technology Midatech Pharma significantly narrowed interim losses in the six months ended 30 June ahead of discussions aimed at licensing its products to drugmakers.
Read moreMidatech raises £10m to continue formulation development
29th Jun 2021 10:53
(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £10m before expenses, it announced on Tuesday, to continue its formulation development work.
Read moreMidatech reports 'encouraging' results from MTX110 study
19th Oct 2020 12:52
(Sharecast News) - Biotechnology company Midatech Pharma announced "encouraging" headline results from a phase 1 study at the University of California, San Francisco (UCSF) in patients with diffuse intrinsic pontine glioma (DIPG) on Monday.
Read moreMidatech raises £5m to fund Q-Sphera development
27th Jul 2020 11:25
(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £5m before expenses via a placing to investors in the UK, it announced on Monday, to advance and develop its 'Q-Sphera' products and technology, and for general corporate purposes.
Read moreMidatech shares skyrocket as it enters new research collaboration
21st Jul 2020 08:29
(Sharecast News) - Drug delivery technology company Midatech Pharma has entered into a research collaboration for the 'Q-Sphera' platform, it announced on Tuesday, with an unnamed European affiliate of a global pharmaceutical company.
Read moreRevenues fall amid 'extremely difficult period' at Midatech
16th Jun 2020 15:32
(Sharecast News) - Drug delivery technology company Midatech Pharma reported a fall in total gross revenue to £0.7m in its final results on Tuesday, from £1.9m year-on-year.
Read moreMidatech raises $2.6m through offering and private placing
21st May 2020 15:54
(Sharecast News) - Biotechnology company Midatech Pharma announced the closing of its registered direct offering of 1,818,182 American depositary shares (ADS), each representing five of its ordinary shares, at a price of $1.65 per ADS on Thursday.
Read moreMidatech sees no reason for share surge
1st May 2020 11:17
(Sharecast News) - Midatech Pharma said it knew of no reason for a surge in its share price on Friday morning.
Read moreMidatech shares surge on success of latest MTD201 study
8th Jan 2020 15:51
(Sharecast News) - Biotechnology research and development company Midatech Pharma announced positive headline results from 'study 102' on Wednesday, which it said met its primary endpoints to confirm similar pharmacokinetics and bioavailability of octreotide for subcutaneous and intramuscular routes of administration.
Read moreMidatech Pharma doses first volunteers in acromegaly treatment study
8th Oct 2019 09:24
(Sharecast News) - Midatech Pharma on Tuesday announced that its MTD201 Phase 1 study for the treatment of acromegaly and neuroendocrine tumours has commenced.
Read moreMidatech Pharma gets approval for next MTD201 study
20th Sep 2019 15:43
(Sharecast News) - Biotechnology company Midatech Pharma has received approval to commence a phase 1 study on MTD201, which it is developing for the treatment of acromegaly and neuroendocrine tumours (NET).
Read moreMidatech Pharma mired in losses as R&D costs mount
24th Apr 2019 11:41
(Sharecast News) - Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.
Read moreMidatech seeking cash after FDA feedback
25th Jan 2019 08:35
(Sharecast News) - Oncology and rare disease-focussed company Midatech Pharma announced on Friday that it has received feedback from the US Food and Drug Administration (FDA) on the regulatory study for its lead product, 'MTD201 Q-Octreotide'.
Read more